Differences in peritumoral pseudocapsule characteristics according to clinicopathological factors in clinical T1a renal tumors.

医学 优势比 嗜酸细胞瘤 置信区间 肾嗜酸细胞瘤 肾细胞癌 病理 内科学 泌尿科 嫌色细胞 肾切除术 清除单元格
作者
Myong Kim,Woo Suk Choi,Chang Wook Jeong,Ja Hyeon Ku,Hyeon Hoe Kim,Kyung Chul Moon,Cheol Kwak
出处
期刊:PubMed 卷期号:8 (9): 11323-31 被引量:10
链接
标识
摘要

To evaluate the status of peritumoral pseudocapsules in renal tumors and the effects of clinicopathological factors on their formation.From January 2011 to December 2012, 258 patients with solitary clinical stage T1a renal tumors who underwent partial nephrectomy were analyzed. Status of pseudocapsule was re-evaluated by a pathologist.The mean long diameter (± SD) of the tumor and the width of the safety margin were 2.17 (± 0.94) cm and 3.2 (± 2.4) mm, respectively. A complete pseudocapsule was identified in 152 (58.9%) tumors, an incomplete pseudocapsule was identified in 69 (26.7%) tumors, and no pseudocapsule was identified in 37 (14.3%) tumors. Out of 152 tumors with complete pseudocapsules, 45 (29.6%) were confirmed to directly invade the renal parenchyma. In a multivariable analysis, age (odds ratio [OR], 1.045; 95% confidence interval [CI], 1.021-1.070, P < 0.001) and histologic subtype (chromophobe type: OR, 19.455; 95% CI, 4.233-89.471, P < 0.001; oncocytoma: OR, 11.307; 95% CI, 1.357-94.198, P = 0.025) were significant factors for an incomplete or absent pseudocapsule.Peritumoral pseudocapsules are absent or incomplete in a significant portion of renal tumors. Old age as well as chromophobe and oncocytoma histologic subtypes were significant risk factors for an incomplete or absent peritumoral pseudocapsule.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
蜡笔小新完成签到,获得积分10
刚刚
1秒前
1秒前
2010完成签到,获得积分10
1秒前
南桥发布了新的文献求助10
2秒前
2秒前
研友_841KWL完成签到,获得积分10
2秒前
cy完成签到,获得积分10
2秒前
yuanbai应助欢喜蛋挞采纳,获得30
2秒前
朱信姿发布了新的文献求助10
4秒前
NexusExplorer应助yutian采纳,获得10
4秒前
ding应助小太阳采纳,获得10
5秒前
想个昵称怪费劲完成签到,获得积分10
5秒前
UUU完成签到 ,获得积分10
5秒前
5秒前
6秒前
6秒前
7秒前
hyman1218完成签到,获得积分10
7秒前
rrrrrr发布了新的文献求助10
7秒前
8秒前
雪兔妹妹完成签到,获得积分10
9秒前
mailure完成签到,获得积分10
9秒前
华仔应助完美的皮卡丘采纳,获得10
9秒前
小蘑菇应助王富贵采纳,获得10
11秒前
11秒前
小彻完成签到,获得积分10
11秒前
11秒前
夏天搞科研完成签到,获得积分20
11秒前
xrjyjp完成签到,获得积分10
13秒前
Ming发布了新的文献求助10
14秒前
量子星尘发布了新的文献求助30
14秒前
zty完成签到 ,获得积分10
14秒前
15秒前
深情安青应助ymr采纳,获得10
16秒前
地西泮完成签到,获得积分10
16秒前
ll发布了新的文献求助10
16秒前
科研蜗牛完成签到,获得积分10
17秒前
笑点低的凉面完成签到,获得积分10
17秒前
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Clinical Microbiology Procedures Handbook, Multi-Volume, 5th Edition 2000
The Cambridge History of China: Volume 4, Sui and T'ang China, 589–906 AD, Part Two 1000
The Composition and Relative Chronology of Dynasties 16 and 17 in Egypt 1000
Russian Foreign Policy: Change and Continuity 800
Real World Research, 5th Edition 800
Qualitative Data Analysis with NVivo By Jenine Beekhuyzen, Pat Bazeley · 2024 800
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5718202
求助须知:如何正确求助?哪些是违规求助? 5251289
关于积分的说明 15284999
捐赠科研通 4868486
什么是DOI,文献DOI怎么找? 2614197
邀请新用户注册赠送积分活动 1564030
关于科研通互助平台的介绍 1521515